These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 8212012
1. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR, Ferris DJ, Tilson HA, Mundy WR. Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [Abstract] [Full Text] [Related]
2. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors. Moret C, Pastrie I, Briley M. Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936 [Abstract] [Full Text] [Related]
3. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. Vickroy TW, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869 [Abstract] [Full Text] [Related]
4. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE. Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [Abstract] [Full Text] [Related]
6. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related]
7. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. Huff RA, Corcoran JJ, Anderson JK, Abou-Donia MB. J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360 [Abstract] [Full Text] [Related]
8. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide. Ehlert FJ, Roeske WR, Yamamura HI. J Supramol Struct; 1980 Apr; 14(2):149-62. PubMed ID: 7230804 [Abstract] [Full Text] [Related]
9. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB, Creese I. Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [Abstract] [Full Text] [Related]
10. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat. Yagle K, Costa LG. Neurotoxicology; 1996 Aug; 17(2):523-30. PubMed ID: 8856746 [Abstract] [Full Text] [Related]
11. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [Abstract] [Full Text] [Related]
12. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ, Jenden DJ. Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [Abstract] [Full Text] [Related]
13. Muscarinic receptors in porcine caudate nucleus. I. Enhancement by nickel and other cations of [3H]cis-methyldioxolane binding to guanyl nucleotide-sensitive sites. Nukada T, Haga T, Ichiyama A. Mol Pharmacol; 1983 Nov; 24(3):366-73. PubMed ID: 6633503 [Abstract] [Full Text] [Related]
14. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW, Binder HJ. Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [Abstract] [Full Text] [Related]
15. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats. Ma T, Kramer RE, Baker RC, Fan LW, Ho IK. J Neurosci Res; 2003 Jan 01; 71(1):138-45. PubMed ID: 12478623 [Abstract] [Full Text] [Related]
16. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. Yamada S, Isogai M, Okudaira H, Hayashi E. J Pharmacol Exp Ther; 1983 Aug 01; 226(2):519-25. PubMed ID: 6875862 [Abstract] [Full Text] [Related]
18. Down-regulation of muscarinic receptors and the m3 subtype in white-footed mice by dietary exposure to parathion. Jett DA, Hill EF, Fernando JC, Eldefrawi ME, Eldefrawi AT. J Toxicol Environ Health; 1993 Jul 01; 39(3):395-415. PubMed ID: 8350385 [Abstract] [Full Text] [Related]
19. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition. Costa LG, Kaylor G, Murphy SD. J Pharmacol Exp Ther; 1986 Oct 01; 239(1):32-7. PubMed ID: 3020234 [Abstract] [Full Text] [Related]
20. Binding studies with [3H]cis-methyldioxolane in different tissues. Under certain conditions [3H]cis-methyldioxolane labels preferentially but not exclusively agonist high affinity states of muscarinic M2 receptors. Closse A, Bittiger H, Langenegger D, Wanner A. Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr 01; 335(4):372-7. PubMed ID: 3600816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]